Intel drops almost 8% after chipmaker reports hefty loss in foundry business

In this article

• INTC

Intel shares fell almost 8% on Wednesday after the company disclosed long-awaited financials in an SEC filing for its semiconductor manufacturing, or foundry, business, revealing an operating loss of $7 billion in 2023.

It was the first time Intel had reported revenue totals for its foundry arm alone, separating it from the products business, which reported $11.3 billion in operating income in 2023.

Intel said Tuesday that it expects its foundry losses to peak in 2024 and break even halfway between the current quarter and the end of 2030.

Analysts at Cantor Fitzgerald, maintaining their neutral rating and $50 price target on the stock, lauded the company for its new financial reporting structure but wrote that Intel will need to drive its foundry and product operating margins higher.

"NOW is when the real work begins," the analysts wrote in a Tuesday investor note. "Of course, this will take time, particularly with Intel's planned manufacturing leadership truly ramping in 2027."

Stifel analysts wrote that they continue to view Intel's strategic plans positively in a note Tuesday while reiterating a hold rating and target price of $45 on the stock.

"With a multi-year execution cycle still ahead, we continue to prefer nearer-term AI beneficiaries, NVDA and AMD," the analysts wrote.

— Our's Kif Leswing contributed to this report.

Don’t miss these stories from Our PRO:

• Five stocks to buy and hold for the long term, according to the pros
• These are Piper Sandler's favorite stocks for the second quarter 
• Energy might be the 'story of the summer,' one chief investment officer says. Here's how to play it
• Alphabet quietly hits new record in down market, forming bullish 'cup-and-handle' chart pattern
• S&P 500 chart analysis shows pullback is likely and investors should hedge
• Cathie Wood buys more Tesla, says now 'is not the time to run for the hills'

Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.